1. Targeting mitochondrial stress with Szeto‐Schiller 31 prevents experimental abdominal aortic aneurysm: Crosstalk with endoplasmic reticulum stress
   Miquel Navas‐Madroñal et al, 2023, British Journal of Pharmacology CrossRef
2. A review of chemotherapeutic drugs-induced arrhythmia and potential intervention with traditional Chinese medicines
   Weina Li et al, 2024, Frontiers in Pharmacology CrossRef
3. Elamipretide alleviates pyroptosis in traumatically injured spinal cord by inhibiting cPLA2-induced lysosomal membrane permeabilization
   Haojie Zhang et al, 2023, Journal of Neuroinflammation CrossRef
4. Modeling drug-induced mitochondrial toxicity with human primary cardiomyocytes
   Xiaoli Tang et al, 2024, Science China Life Sciences CrossRef
5. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
   Pushkar Singh Rawat et al, 2021, Biomedicine & Pharmacotherapy CrossRef
6. Doxorubicin Nanomedicine Based on Ginsenoside Rg1 with Alleviated Cardiotoxicity and Enhanced Antitumor Activity
   Chaoqi Li et al, 2021, Nanomedicine CrossRef
7. Application research of novel peptide mitochondrial-targeted antioxidant SS-31 in mitigating mitochondrial dysfunction
   Xinrong Du et al, 2024, Mitochondrion CrossRef
8. Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy
   Wenyao Zhen et al, 2021, Advanced Materials CrossRef
9. Development and Characterization of Innovative Multidrug Nanoformulation for Cardiac Therapy
   Amandine Gendron et al, 2023, Materials CrossRef
10. Cardiomyocyte Atrophy, an Underestimated Contributor in Doxorubicin-Induced Cardiotoxicity
    De-Shu Chen et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
11. Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
    Yifei Rao et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
12. Current perspectives of mitochondria-targeted antioxidants in cancer prevention and treatment
    Roman A. Zinovkin et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
13. Mitochondria-targeting peptide SS-31 attenuates ferroptosis via inhibition of the p38 MAPK signaling pathway in the hippocampus of epileptic rats
    Xue Liu et al, 2024, Brain Research CrossRef
14. Mitochondrial dysfunction and mitochondrial therapies in heart failure
    Chennan Wu et al, 2022, Pharmacological Research CrossRef
15. The Therapeutic Strategies Targeting Mitochondrial Metabolism in Cardiovascular Disease
    Xiaoyang Huang et al, 2022, Pharmaceutics CrossRef